However, it remains to be determined whether flow cytometric quantification of β2-AR density on blood cells, such as lymphocytes, may be useful to monitor treatment responses, disease activity, and prognosis of diseases involving changes in β-AR density, such as heart failure. This evidence concerns the gene ADRB2 and heart failure.